Clinical Trial Update: XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for XIENCE V USA Dual Antiplatelet Therapy cohort; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis
• Coronary Disease
• Coronary Restenosis
• Myocardial Ischemia
• Total Occlusion of Coronary Artery
• Vascular Disease

Drugs mentioned

• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Total Occlusion of Coronary Artery, Vascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-06-28